Global Antacids Market Share, Industry Trends and Forecast 2024-2032

No comments

IMARC Group, a leading market research company, has recently releases report titled “Antacids Market Report by Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents), Formulation Type (Tablet, Liquid, Powder, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the global antacids market.

How Big is the Antacids Market?

The global antacids market size reached US$ 6.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032.

Factors Affecting the Growth of the Antacids Industry:

  • Increasing Prevalence of Gastrointestinal Disorders:

One of the primary drivers of the antacids market is the rising incidence of gastrointestinal disorders such as acid reflux, heartburn, and indigestion. Factors such as unhealthy dietary habits, stress, obesity, and sedentary lifestyles contribute to the prevalence of these conditions. Antacids provide quick relief by neutralizing stomach acid and alleviating symptoms, making them a popular choice for individuals suffering from occasional or chronic digestive discomfort. As the global population continues to grow and age, with a simultaneous increase in lifestyle-related diseases, the demand for antacids is expected to escalate, driving market growth.

  • Rising Consumer Preference for OTC Remedies:

The shift toward self-medication and the preference for OTC remedies for minor ailments are driving the demand for antacids. Consumers value convenience, accessibility, and affordability, making antacids an attractive option for managing mild digestive issues without the need for a prescription. OTC antacid products offer a wide range of formulations, flavors, and dosage forms, catering to diverse consumer preferences and lifestyles. With busy schedules and limited time for healthcare appointments, individuals often seek immediate relief from symptoms through easily accessible antacid solutions, stimulating market expansion.

Other Post You May Be Interested In

  • Growing Geriatric Population:

The aging population, coupled with an increase in chronic health conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers, is driving the demand for antacids. Elderly individuals are more susceptible to digestive disorders due to physiological changes in the gastrointestinal tract, medication use, and comorbidities. Antacids offer a safe and effective treatment option for managing symptoms and improving quality of life in older adults. As the proportion of seniors continues to grow globally, particularly in developed regions, the market for antacids is expected to witness sustained growth due to the ongoing healthcare needs of this demographic segment.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/antacids-market/requestsample

Leading Companies Operating in the Global Antacids Industry:

  • Abbott Laboratories
  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy’s Laboratories Ltd.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Procter & Gamble Company
  • Reckitt Benckiser Group PLC
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited.

Antacids Market Report Segmentation:

By Drug Class:

  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
  • Pro-Motility Agents

Proton pump inhibitors dominate the market as they are highly effective in treating gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related disorders.

By Formulation Type:

  • Tablet
  • Liquid
  • Powder
  • Others

Tablets hold the largest market share as they offer convenience and ease of use for consumers.

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Retail pharmacy accounts for the largest market share as they are easily accessible to consumers, with many located in convenient locations such as shopping centers, neighborhoods, and online platforms.

Regional Insights:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Asia Pacific’s dominance in the antacids market is attributed to changing dietary habits, increasing consumption of spicy and fatty foods, and lifestyle factors such as stress and sedentary behavior.

Global Antacids Market Trends:

Presently, there is a growing consumer preference for over the counter (OTC) antacid products driven by factors such as convenience, accessibility, and cost-effectiveness. Consumers are increasingly opting for self-medication for mild digestive discomfort, leading to increased sales of antacid products in pharmacies, supermarkets, and online channels.

Additionally, there is a rising demand for fast-acting and long-lasting antacid formulations that provide quick relief from symptoms such as heartburn, acid reflux, and indigestion. Pharmaceutical companies are innovating new antacid formulations with advanced delivery systems and optimized dosages to meet these evolving consumer needs and preferences.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

SHARE NOW
Tagged with ,

Leave a Reply

Your email address will not be published. Required fields are marked *